In MLL-rearranged AML, certain MLL fusion proteins display enhanced activity to promote gene transcription by recruiting a transcriptional activation complex known as P-TEFb that consists of CDK9 and cyclin T1 [47, 48]. The gene discussed is CCNT1; the disease is acute myeloid leukemia.